FDG-PET for the diagnosis of fever of unknown origin: A Japanese multi-center study

Annals of Nuclear Medicine

Volumn 25, Issue 5, 2011, Pages 355-364

  Kubota, Kazuo ^a   Nakamoto, Yuji ^b   Tamaki, Nagara ^c   Kanegae, Kakuko ^c,g   Fukuda, Hiroshi ^d   Kaneda, Tomohiro ^d   Kitajima, Kazuhiro ^e   Tateishi, Ukihide ^f   Morooka, Miyako ^a   Ito, Kimiteru ^a,h   Minamimoto, Ryogo ^a   Murakami, Koji ^e,i  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

^e DOKKYO MEDICAL UNIVERSITY   (Japan)

^f YOKOHAMA CITY UNIVERSITY   (Japan)

^g Keiyukai Sapporo Hospital   (Japan)

^h NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

ⁱ KEIO UNIVERSITY HOSPITAL   (Japan)

Author keywords

FDG PET; Fever of unknown origin; Infectious disease; Inflammation; Multi center study

Indexed keywords

FLUORODEOXYGLUCOSE F 18; STEROID;

ADULT; AGED; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; COLLAGEN DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; GRANULOMA; HUMAN; IMAGE ANALYSIS; INFECTION; JAPANESE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STEROID THERAPY; TUMOR; VASCULITIS;

FEMALE; FEVER OF UNKNOWN ORIGIN; FLUORODEOXYGLUCOSE F18; HUMANS; JAPAN; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES;

EID: 80052334028     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-011-0470-6     Document Type: Article

References (24)

1. Tahara T, Ichiya Y, Kuwabara Y, Otsuka M, Miyake Y, Gunasekera R, et al. High [18F]fluorodeoxyglucose uptake in abdominal abscess: a PET study. J Comput Assist Tomogra. 1989;13:829-31. (Pubitemid 19245076)
2. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo; high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972-80.
3. Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentineinduced inflammatory tissue. J Nucl Med. 1995;36:1301-6.
4. Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med. 2007;48:35-45. (Pubitemid 47555372)
5. Bleeker-Rovers CP, van der Meer JWM, Oyen WJG. Fever of unknown origin. Semin Nucl Med. 2009;39:81-7.
6. Beckers C, Ribbens C, Andre B, Marcelis S, Kaya O, Mathy L, et al. Assessments of disease activity in rheumatoid arthritis with 18F-FDG PET. J Nucl Med 2004;45:956-64. (Pubitemid 47611682)
7. Kubota K, Ito K, Morooka M, Mitsumoto T, Kurihara K, Yamashita H, Takahashi Y, Mimori A. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints. Ann Nucl Med. 2009; 23:783-91.
8. Ito K, Kubota K, Morooka M, Hasuo K, Kuroki H, Mimori A. Clinical impact of 18F-FDG PET/CT on the management and diagnosis of infectious spondylitis. Nucl Med Comm. 2010;31: 691-8.
9. Webb M, Chambers A, AL-Nahhas A, Mason JC, Maudlin L, Rahman L, Frank J. The role of 18F-FDG PET in characterizing disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging. 2004;31:627-34. (Pubitemid 38647900)
10. Neurath MF, Vehling D, Schunk K, Holtmann M, Brockmann H, Helisch A, Orth T, Schreckenberger M, Galle PR, Bartenstein P. Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. Am J Gastroenterol. 2002;97:1978-85.
11. Meller J, Altenvoerde G, Munzel U, Jauho A, Behe M, Gratz S, Luig H, Becker W. Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med. 2000;27: 1617-25.
12. Blockmans D, Knockaert D, Maes A, De Caestecker J, Stroobants S, Bobbaers H, Mortelmans L. Clinical value of [18F]fluorodeoxyglucose PET for patients with fever of unknown origin. Clin Infect Dis. 2001;32:191-6. (Pubitemid 32524787)
13. Lorenzen J, Buchert R, Bohuslavizki KH. Value of FDG PET in patients with fever of unknown origin. Nucl Med Comm. 2001;22:779-83. (Pubitemid 32613439)
14. Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging. 2004;31:29-37. (Pubitemid 38133538)
15. Kjaer A, Lebech AM, Eigtved A, Højgaard L. Fever of unknown origin: prospective comparison of diagnostic value of 18F-FDG PET and 111In-grnulocyte scintigraphy. Eur J Nucl Med Mol Imaging. 2004;31:622-6. (Pubitemid 38647899)
16. Buysschaert I, Vnderschueren S, Blockmans D, Mortelmans L, Knockaert D. Conribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin. Eur J Intern Med. 2004;15:151-6. (Pubitemid 38900559)
17. Bleeker-Rovers CP, Vos FJ, Mudde AH, Dofferhoff ASM, Geus- Oei LFD, Rijnders AJ, et al. A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin. Eur J Nucl Med Mol Imaging. 2007;34:694-703. (Pubitemid 46669364)
18. Keidar Z, Gurman-Balbir A, Gaitini D, Israel O. Fever of unknown origin: the role of 18F-FDG PET/CT. J Nucl Med. 2008;49:1980-5.
19. Baling H, Collins J, Bruyn G, Gemmel F. F-18 FDG PET/CT in the diagnosis of fever of unknown origin. Clin Nucl Med. 2009;34:862-8.
20. Federici L, Blondet C, Imperiale A, Sibilia J, Pasquali JL, Pflumio F, et al. Value of 18F-FDG-PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experience. Int J Clin Pract. 2010;64:55-60.
21. Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine. 1961;40:1-30.
22. Simons KS, Pickkers P, Bleeker-Rovers CP, Oyen WJ, van der Hoeven JG. F-18-fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection. Intensive Care Med. 2010;36:504-11.
23. Castaigne C, Tondeur M, De Wit S, Hildebrand M, Clumeck N, Dusart M. Clinical value of FDG-PET for the diagnosis of human immunodeficiency virus-associated fever of unknown origin: a retrospective study. Nucl Med Comm. 2009;30:41-7.
24. Brust D, Polis M, Davey R, Hahn B, Bacharach S, Whatley M, Fauci AS, Carrasquillo JA. Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation. AIDS. 2006;20:495-503. (Pubitemid 43731593)